Key points are not available for this paper at this time.
Treatment with tebentafusp resulted in longer overall survival than the control therapy among previously untreated patients with metastatic uveal melanoma. (Funded by Immunocore; ClinicalTrials.gov number, NCT03070392; EudraCT number, 2015-003153-18.).
Building similarity graph...
Analyzing shared references across papers
Loading...
New England Journal of Medicine
Massachusetts General Hospital
Duke University
Memorial Sloan Kettering Cancer Center
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Nathan et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: